Management of Increased Reactivity on Adderall XR 5 mg

Assessment of Increased Reactivity

Evaluate the nature and timing of reactivity symptoms to determine if the medication dose is too high or not suitable for the patient 2
Determine if reactivity occurs at peak medication levels or during medication wear-off periods 1
Rule out other factors contributing to increased reactivity, such as inadequate sleep, caffeine intake, or comorbid anxiety disorders 1

Consider reducing the dose or implementing behavioral strategies to manage reactivity if the patient is experiencing benefit from the medication despite reactivity 2
Ensure the medication is taken in the morning to minimize potential sleep disturbances that could worsen reactivity 3
Consider switching to a different stimulant formulation, such as methylphenidate, if reactivity persists despite dose adjustments 2
For patients with significant anxiety or emotional reactivity, non-stimulant options like atomoxetine, bupropion, or viloxazine may be more appropriate 4
Dialectical Behavior Therapy (DBT) can be considered as an adjunctive non-pharmacological treatment for emotional regulation in adults with ADHD 4

Schedule a follow-up appointment within 2-4 weeks to reassess symptoms 1
Use standardized rating scales to objectively measure changes in ADHD symptoms and side effects 1
Monitor vital signs, particularly blood pressure and heart rate, as stimulants can cause cardiovascular effects 3
Assess for common side effects such as insomnia, decreased appetite, and weight loss 3

Starting at too high a dose is a common pitfall in stimulant therapy; Adderall XR should be initiated at the lowest effective dose and titrated gradually 3
Failure to systematically assess both benefits and side effects during treatment can lead to inappropriate medication adjustments 1
Not allowing sufficient time between dose changes to evaluate response (at least one week) is another common pitfall 3

For older adults, consider a more conservative titration schedule due to potential increased sensitivity to both therapeutic and adverse effects 1